Caina Technology Co

Caina Technology Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 3.22 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 65.45 M CNY — a change of -95.08% (lower).

EBITDA

3.22 MCNY

YoY

-95.08%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Caina Technology Co is 2025 3.22 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Caina Technology Co was 2024 65.45 M CNY. It decreases by -95.08% lower compared to the previous year.

The Caina Technology Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
24.81 M CNY
Jan 1, 2019
44.17 M CNY
Jan 1, 2020
167.66 M CNY
Jan 1, 2021
156.77 M CNY
Jan 1, 2022
184.60 M CNY
Jan 1, 2023
134.70 M CNY
Jan 1, 2024
65.45 M CNY
Jan 1, 2025
3.22 M CNY
The Caina Technology Co EBITDA history
YEAREBITDAYoY
3.22 MCNY-95.08%
65.45 MCNY-51.41%
134.70 MCNY-27.03%
184.60 MCNY+17.75%
156.77 MCNY-6.50%
167.66 MCNY+279.57%
44.17 MCNY+78.07%
24.81 MCNY+95.74%
12.67 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Caina Technology Co is 3.22 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Caina Technology Co changed from 65.45 M CNY to 3.22 M CNY, representing a -95.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Caina Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Caina Technology Co

All Key Metrics — Caina Technology Co